The associations among cortisol levels, body water status, and acute mountain sickness (AMS) remain unclear. We investigated associations between AMS prevalence and severity with resting saliva cortisol levels at low altitude (LA) and high altitude (HA) and with fluid balance during a HA stay.
Methods:
Twenty-two physically fit and healthy participants (12 women, 10 men) were transported to HA (Testa Grigia, 3480 m). In the late afternoon at LA, on the next day 3–4 hours after arrival at HA and in the morning after an overnight stay, heart rate, oxygen saturation, and systolic and diastolic blood pressures were measured in a sitting position after 10 minutes of rest; cortisol levels were quantified in saliva samples taken pre-ascent and 3–4 hours after arrival at HA. AMS was scored with the 1993 Lake Louise Score (LLS, cut-off ≥3). Urine volume and fluid and food intake were recorded during the altitude stay.
Results:
Pre-ascent cortisol levels were associated with fluid retention during the altitude stay (r2 = 0.33, p < 0.05) and both were positively related to the LLS (r2 = 0.49 and r2 = 0.26, p < 0.05, respectively).
Conclusions:
In conclusion, resting LA cortisol levels and fluid retention upon rapid exposure to altitude seem to be associated with AMS. This suggests a potential link among cortisol homeostasis, fluid balance, and AMS risk.
BaileyDM, TaudorfS, BergRM, LundbyC, McEnenyJ, YoungIS, EvansKA, JamesPE, ShoreA, HullinDA, McCordJM, PedersenBK, and MöllerK. (2009). Increased cerebral output of free radicals during hypoxia: Implications for acute mountain sickness?. Am J Physiol Regul Integr Comp Physiol, 297:R1283–R1292.
3.
BärtschP, PflugerN, AudétatM, ShawS, WeidmannP, VockP, VetterW, RennieD, and OelzO. (1991). Effects of slow ascent to 4559 M on fluid homeostasis. Aviat Space Environ Med, 62:105–110.
4.
BasnyatB, and MurdochDR. (2003). High-altitude illness. Lancet, 361:1967–1974.
5.
BoosCJ, BassM, O'HaraJP, VincentE, MellorA, SevierL, Abdul-RazakqH, CookeM, BarlowM, and WoodsDR. (2018). The relationship between anxiety and acute mountain sickness. PLoS One, 13:e0197147.
6.
BurtscherM, BrandstatterE, and GattererH. (2008). Preacclimatization in simulated altitudes. Sleep Breath, 12:109–114.
7.
BurtscherM, FlatzM, and FaulhaberM. (2004). Prediction of susceptibility to acute mountain sickness by SaO2 values during short-term exposure to hypoxia. High Alt Med Biol, 5:335–340.
8.
BurtscherM, MairerK, WilleM, and BroessnerG. (2011). Risk factors for high-altitude headache in mountaineers. Cephalalgia, 31:706–711.
9.
CarrPJ, MillarRP, and CrowleyH. (1977). A simple radioimmunoassay for plasma cortisol: Comparison with the fluorimetric method of determination. Ann Clin Biochem, 14:207–211.
10.
CerretelliP, and SamajaM. (2003). Acid-base balance at exercise in normoxia and in chronic hypoxia. Revisiting the “lactate paradox.”. Eur J Appl Physiol, 90:431–448.
11.
ChanPH, SchmidleyJW, FishmanRA, and LongarSM. (1984). Brain injury, edema, and vascular permeability changes induced by oxygen-derived free radicals. Neurology, 34:315–320.
12.
El-FarhanN, ReesDA, and EvansC. (2017). Measuring cortisol in serum, urine and saliva—Are our assays good enough?. Ann Clin Biochem, 54:308–322.
13.
ErmolaoA, TravainG, FaccoM, ZilliC, AgostiniC, and ZaccariaM. (2009). Relationship between stress hormones and immune response during high-altitude exposure in women. J Endocrinol Invest, 32:889–894.
14.
FerrazziniG, MaggioriniM, KriemlerS, BartschP, and OelzO. (1987). Successful treatment of acute mountain sickness with dexamethasone. Br Med J (Clin Res Ed), 294:1380–1382.
15.
FrayserR, RennieID, GrayGW, and HoustonCS. (1975). Hormonal and electrolyte response to exposure to 17,500 ft. J Appl Physiol, 38:636–642.
16.
GarrodO. (1958). The pharmacology of cortisone, cortisol (hydrocortisone) and their new analogues. Postgrad Med J, 34:300–304.
17.
GattererH, WilleM, FaulhaberM, LukaskiH, MelmerA, EbenbichlerC, and BurtscherM. (2013). Association between body water status and acute mountain sickness. PLos One, 8:e73185.
18.
HackettPH, and RoachRC. (2001). High-altitude illness. N Engl J Med, 345:107–114.
19.
HumpelerE, SkrabalF, and BartschG. (1980). Influence of exposure to moderate altitude on the plasma concentraton of cortisol, aldosterone, renin, testosterone, and gonadotropins. Eur J Appl Physiol Occup Physiol, 45:167–176.
20.
IrarrázavalS, AllardC, CampodónicoJ, PérezD, StrobelP, VásquezL, UrquiagaI, EcheverríaG, and LeightonF. (2017). Oxidative stress in acute hypobaric hypoxia. High Alt Med Biol, 18:128–134.
21.
KayserB, DumontL, LysakowskiC, CombescureC, HallerG, and TramerMR. (2012). Reappraisal of acetazolamide for the prevention of acute mountain sickness: A systematic review and meta-analysis. High Alt Med Biol, 13:82–92.
22.
LafuenteJV, BermudezG, Camargo-ArceL, and BulnesS. (2016). Blood-brain barrier changes in high altitude. CNS Neurol Disord Drug Targets, 15:1188–1197.
23.
LawleyJS, LevineBD, WilliamsMA, MalmJ, EklundA, PolanerDM, SubudhiAW, HackettPH, and RoachRC. (2016). Cerebral spinal fluid dynamics: Effect of hypoxia and implications for high-altitude illness. J Appl Physiol (1985), 120:251–262.
24.
LevineBD, YoshimuraK, KobayashiT, FukushimaM, ShibamotoT, and UedaG. (1989). Dexamethasone in the treatment of acute mountain sickness. N Engl J Med, 321:1707–1713.
25.
LoeppkyJA, IcenogleMV, MaesD, RiboniK, Hinghofer-SzalkayH, and RoachRC. (2005). Early fluid retention and severe acute mountain sickness. J Appl Physiol (1985), 98:591–597.
26.
LoeppkyJA, IcenogleMV, MaesD, RiboniK, ScottoP, and RoachRC. (2003). Body temperature, autonomic responses, and acute mountain sickness. High Alt Med Biol, 4:367–373.
MissoumG, RosnetE, and RichaletJP. (1992). Control of anxiety and acute mountain sickness in Himalayan mountaineers. Int J Sports Med 13 Suppl, 1:37–39.
29.
RichaletJP, RutgersV, BouchetP, RymerJC, KéromèsA, Duval-ArnouldG, and RathatC. (1989). Diurnal variations of acute mountain sickness, colour vision, and plasma cortisol and ACTH at high altitude. Aviat Space Environ Med, 60:105–111.
30.
RoachRC, BärtschP, HackettPH, and OelzO. (1993). The lake louise acute mountain sickness scoring system. In: Hypoxia and Molecular Medicine. JR Sutton, C Houston, and G Coates, eds. Queen City Press, Burlington, pp. 272–274.
31.
RoachRC, and HackettPH. (2001). Frontiers of hypoxia research: Acute mountain sickness. J Exp Biol, 204:3161–3170.
32.
SawhneyRC, MalhotraAS, and SinghT. (1991). Glucoregulatory hormones in man at high altitude. Eur J Appl Physiol Occup Physiol, 62:286–291.
33.
SmithJD, CianfloneK, MartinJ, PoirierP, BroderickTL, and NoëlM. (2011). Plasma adipokine and hormone changes in mountaineers on ascent to 5300 meters. Wilderness Environ Med, 22:107–114.
34.
SuttonJR, ViolGW, GrayGW, McFaddenM, and KeanePM. (1977). Renin, aldosterone, electrolyte, and cortisol responses to hypoxic decompression. J Appl Physiol Respir Environ Exerc Physiol, 43:421–424.
35.
SwensonER, and OlsenNV. (2014). Renal function and fluid homeostasis. In: High Altitude—Human Adaptation to Hypoxia. ER Swenson, and P Bärtsch, eds. Springer, New York. pp. 217–236.
36.
SwensonER. (2016). Pharmacology of acute mountain sickness: Old drugs and newer thinking. J Appl Physiol (1985), 120:204–215.
37.
TaylorMK, ReisJP, SausenKP, PadillaGA, MarkhamAE, PotteratEG, and DrummondSP. (2008). Trait anxiety and salivary cortisol during free living and military stress. Aviat Space Environ Med, 79:129–135.
38.
Torres-RuizJ, SulliA, CutoloM, and ShoenfeldY. (2017). Air travel, circadian rhythms/hormones, and autoimmunity. Clin Rev Allergy Immunol, 53:117–125.
39.
WesterterpKR, RobachP, WoutersL, and RichaletJP. (1996). Water balance and acute mountain sickness before and after arrival at high altitude of 4,350 m. J Appl Physiol (1985), 80:1968–1972.
40.
WhitworthJA, MangosGJ, and KellyJJ. (2000). Cushing, cortisol, and cardiovascular disease. Hypertension, 36:912–916.
41.
WhitworthJA, WilliamsonPM, MangosG, and KellyJJ. (2005). Cardiovascular consequences of cortisol excess. Vasc Health Risk Manag, 1:291–299.
42.
WoodsDR, DavisonA, StaceyM, SmithC, HooperT, NeelyD, TurnerS, PeastonR, and MellorA. (2012). The cortisol response to hypobaric hypoxia at rest and post-exercise. Horm Metab Res, 44:302–305.
43.
WortsmanJ. (2002). Role of epinephrine in acute stress. Endocrinol Metab Clin North Am, 31:79–106.
44.
YoungJA, CookDI, EvansLA, and PiraniD. (1987). Effects of ion transport inhibition on rat mandibular gland secretion. J Dent Res, 66:531–536.
